Compare the Efficacy and Safety of Intranasal Esketamine in Chronic Opioid Refractory Pain
Clinical trial NCT04666623 · WITHDRAWN
Trial details
- NCT number
- NCT04666623
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-25
- Primary completion
- 2023-10-11
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.